GlassScriptPhysician profile
Daniel Dean
NPI 1841680501
$35,734.46
in general payments reported to CMS, 2019-2025
20 companies · $2,438 in 2025
The $2,438 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,269 · 2020: $12K · 2021: $7,284 · 2022: $3,499 · 2023: $4,674 · 2024: $3,669 · 2025: $2,438.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,058 · Food and Beverage: $3,931 · Education: $792.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,057.60 |
| Food and Beverage | $3,930.83 |
| Education | $792.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $17,329.95 | 2020-2025 | |
| Stryker Corporation | $6,496.30 | 2019-2025 | Infinity, Inbone, Augment Injectable |
| Paragon 28, INC. | $2,784.08 | 2020-2025 | Apex 3d, Plating Portfolio, R3flex |
| Supreme Orthopedic Systems, LLC | $2,315.63 | 2020-2021 | |
| Medwest Associates | $2,045.04 | 2022-2023 | |
| Medical Device Business Services, INC. | $1,680.32 | 2019-2020 | |
| Oak Med, INC. | $747.20 | 2025 | |
| International Life Sciences | $537.80 | 2023 | |
| Nuvasive, INC. | $514.91 | 2019-2020 | |
| Exactech, INC. | $494.74 | 2021 | |
| Depuy Synthes Sales INC. | $330.21 | 2019-2025 | Va-Lcp |
| Si-Bone, INC. | $145.50 | 2020 | |
| Treace Medical Concepts, INC. | $74.87 | 2024 | |
| Orthofix Medical, INC. | $65.74 | 2021-2025 | Physio-Stim |
| Zimmer Biomet Holdings, INC. | $65.42 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $29.75 | 2025 | Prevena |
| Davol INC. | $23.77 | 2020 | |
| Linvatec Corporation | $21.90 | 2024 | Biobrace 23mm |
| Mimedx Group, INC. | $17.86 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $13.47 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Dean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.